Enter a Search String |
| Special character and space not allowed in the query term. Search string should be at least 2 characters long. |
Molecule Parameter List for PKA-active | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network. The text color of a molecule is highlighted by color. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statistics | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PKA-active participated as | Molecule | Sum total of | Enzyme | Substrate of an enzyme | Product of an enzyme | Substrate in Reaction | Product in Reaction |
| No. of occurrences | 1 | 0 | 35 | 0 | 0 | 1 | 2 |
Accession and Pathway Details |
| Accession Name | Accession No. | Accession Type | Pathway Link |
model1 | 60 | Network | Shared_Object_AMPAR_traff_model1, CaMKII, CaM, PP1, PP2B, PP1_PSD, PKA, AC, AMPAR, AMPAR_memb |
| This is the basic model of AMPAR trafficking bistability. It is based on Hayer and Bhalla, PLoS Comput. Biol. 2005. It includes the degradation and turnover of AMPARs. The CaMKII portion of the model is not bistable. | |||
PKA-active acting as a Molecule in AMPAR_traff_model1 Network
| Name | Accession Name | Pathway Name | Initial Conc. (uM) | Volume (fL) | Buffered | |
| PKA-active | model1 Accession No. : 60 | PKA Pathway No. : 250 | 0 | 0.09 | No | |
PKA-active acting as an Enzyme in AMPAR_traff_model1 Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | PKA-active / phosph-PDE | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50008 | 9 | 4 | explicit E-S complex | Substrate cAMP-PDE Product cAMP-PDE* |
| Same rates as PKA-phosph-I1 | ||||||||
| 2 | PKA-active / PKA-phosph-I1 | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50008 | 9 | 4 | explicit E-S complex | Substrate I1 Product I1* |
| #s from Bramson et al CRC crit rev Biochem 15:2 93-124. They have a huge list of peptide substrates and I have chosen high-ish rates. These consts give too much PKA activity, so lower Vmax 1/3. Now, k1 = 3e-5, k2 = 36, k3 = 9 (still pretty fast). Also lower Km 1/3 so k1 = 1e-5 Cohen et al FEBS Lett 76:182-86 1977 say rate =30% PKA act on phosphokinase beta. | ||||||||
| 3 | PKA-active / PSD | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50008 | 9 | 4 | explicit E-S complex | Substrate I1 Product I1* |
| 4 | PKA-active / PKA[17] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B Product A845*_B |
| 5 | PKA-active / PKA[16] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B Product A831*845*_B |
| 6 | PKA-active / PKA[18] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831* Product A845*_B831* |
| 7 | PKA-active / PKA[19] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831* Product A831*845*_B831* |
| 8 | PKA-active / PKA[20] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B Product A_B845* |
| 9 | PKA-active / PKA[21] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B Product A831*_B845* |
| 10 | PKA-active / PKA[22] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831* Product A_B831*845* |
| 11 | PKA-active / PKA[23] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831* Product A831*_B831*845* |
| 12 | PKA-active / PKA[24] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B845* Product A845*_B845* |
| 13 | PKA-active / PKA[25] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B845* Product A831*845*_B845* |
| 14 | PKA-active / PKA[26] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831*845* Product A845*_B831*845* |
| 15 | PKA-active / PKA[27] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831*845* Product B835*845* |
| 16 | PKA-active / PKA[28] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A845*_B Product A845*_B845* |
| 17 | PKA-active / PKA[29] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*845*_B Product A831*845*_B845* |
| 18 | PKA-active / PKA[30] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A845*_B831* Product A845*_B831*845* |
| 19 | PKA-active / PKA[31] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*845*_B831* Product B835*845* |
| 20 | PKA-active / PKA | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B845* Product A845*_B845* |
| 21 | PKA-active / PKA[1] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A845*_B Product A845*_B845* |
| 22 | PKA-active / PKA[2] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B Product A845*_B |
| 23 | PKA-active / PKA[3] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B Product A_B845* |
| 24 | PKA-active / PKA[4] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B845* Product A831*845*_B845* |
| 25 | PKA-active / PKA[5] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*845*_B Product A831*845*_B845* |
| 26 | PKA-active / PKA[6] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B Product A831*_B845* |
| 27 | PKA-active / PKA[7] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B Product A831*845*_B |
| 28 | PKA-active / PKA[8] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831*845* Product A845*_B831*845* |
| 29 | PKA-active / PKA[9] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A845*_B831* Product A845*_B831*845* |
| 30 | PKA-active / PKA[10] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831* Product A_B831*845* |
| 31 | PKA-active / PKA[11] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A_B831* Product A845*_B831* |
| 32 | PKA-active / PKA[12] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831*845* Product B835*845* |
| 33 | PKA-active / PKA[13] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*845*_B831* Product B835*845* |
| 34 | PKA-active / PKA[14] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831* Product A831*_B831*845* |
| 35 | PKA-active / PKA[15] | model1 Accession No. : 60 | PKA Pathway No. : 250 | 7.50021 | 6 | 4 | explicit E-S complex | Substrate A831*_B831* Product A831*845*_B831* |
PKA-active acting as a Substrate in a reaction in AMPAR_traff_model1 Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents |
| inhib-PKA | model1 Accession No. : 60 | PKA Pathway No. : 250 | 59.9994 (uM^-1 s^-1) | 1 (s^-1) | Kd(bf) = 0.0167(uM) | - | Substrate PKA-active PKA-inhibitor Product inhibited-PKA |
| This has to be set to zero for matching the expts in vitro. In vivo we need to consider the inhibition though. kf = 1e-5 kb = 1 | |||||||
PKA-active acting as a Product in a reaction in AMPAR_traff_model1 Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents | |
| 1 | Release-C1 | model1 Accession No. : 60 | PKA Pathway No. : 250 | 60 (s^-1) | 17.9998 (uM^-1 s^-1) | Kd(cb) = 0.3(uM) | - | Substrate R2C2-cAMP4 Product PKA-active R2C-cAMP4 |
| This has to be fast, as the activation of PKA by cAMP is also fast. kf was 10 | ||||||||
| 2 | Release-C2 | model1 Accession No. : 60 | PKA Pathway No. : 250 | 60 (s^-1) | 17.9998 (uM^-1 s^-1) | Kd(cb) = 0.3(uM) | - | Substrate R2C-cAMP4 Product PKA-active R2-cAMP4 |
color.